Mouse parabiosis study: endothelial IGF-1/IGF-1R signaling in young-blood vascular restoration
In aged mice joined to young circulation, blood-brain barrier leakage fell and cortical capillary density rose; deleting endothelial IGF-1 receptors or lowering systemic IGF-1 in the young partner weakened these effects, though partial improvement remained. [1]
Automatic summary · not editorially reviewed
The key findings
Aging is associated with blood-brain barrier breakdown and microvascular rarefaction, and young circulation via heterochronic parabiosis had been reported to restore barrier integrity in aged mice. [1]
In aged mice exposed to young circulation, barrier leakage to fluorescent tracers fell markedly and cortical capillary density rose. [1]
The benefits were significantly attenuated without endothelial IGF-1R or with young partners lacking systemic IGF-1, yet partial improvement persisted, so IGF-1/IGF-1R signaling contributes but does not fully account for them. [1]
The source at a glance
- Study type / format
- Preclinical mouse study (abstract)
- Population / context
- Aged mice in a heterochronic parabiosis model, including transgenic lines with endothelial IGF-1R deletion or systemic IGF-1 knockdown.
- Summary based on
- Study abstract
- Original publication
- August 20, 2026
Aged mice, young circulation and IGF-1 hypothesis
The abstract links aging with blood-brain barrier breakdown and loss of small blood vessels in the brain. In aged mice, exposure to young circulation through heterochronic parabiosis — surgically joining the circulations of an old and a young animal — had been reported to restore barrier integrity and cerebrovascular function. The authors note that circulating insulin-like growth factor-1 (IGF-1) declines with age and has been linked to endothelial dysfunction and barrier disruption. They therefore asked whether IGF-1 signaling through its receptor (IGF-1R) on endothelial cells contributes to the vascular rejuvenation seen with young blood.
Supporting source [1]
Transgenic IGF-1/IGF-1R manipulations and microscopy outcomes
The researchers combined parabiosis with transgenic approaches: deleting endothelial IGF-1R (VE-Cadherin-CreERT2/Igf1rfl/fl) or knocking down systemic IGF-1 (TBG-Cre-AAV8/Igf1fl/fl). They measured barrier permeability to fluorescent tracers and cortical microvascular density using intravital two-photon microscopy through chronic cranial windows. Aged mice exposed to young circulation showed markedly reduced barrier leakage and increased cortical capillary density. These benefits were significantly attenuated when aged parabionts lacked endothelial IGF-1R or were paired with young partners deficient in systemic IGF-1. Partial improvement persisted, so IGF-1/IGF-1R signaling contributes to, but does not fully explain, the vascular benefits.
Supporting source [1]
Abstract-only mouse evidence and proposed geroscience strategies
The findings identify the IGF-1/IGF-1R axis as an important mediator of young-blood-induced restoration of barrier integrity and microvascular density in this mouse model. The abstract proposes that targeting downstream effectors of IGF-1R signaling, together with lifestyle interventions that enhance somatotropic axis responsiveness, may offer geroscience-guided strategies to preserve barrier function and cognitive resilience in aging. These are proposals, not validated treatments. The abstract does not report sample sizes, follow-up duration or effect sizes, and the full text was not reviewed. Results come from aged mice in a parabiosis model and do not establish human lifespan or cognitive benefits.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. The abstract reports no sample sizes, follow-up duration or effect sizes. Findings are from aged mice in a parabiosis model and do not establish human lifespan or cognitive benefits; proposed strategies are not validated treatments.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Gulej R, Kristof R, Patai R, Chandragiri SS, Ekambaram S, Nagykaldi M, Brunner E, Mukli P, Nyul-Toth A, Nagy D, Kordestan KV, Nagaraja RY, Shanmugarama S, Yabluchanskiy A, Tarantini S, Ungvari Z, Csiszar A. · europepmc.org · August 20, 2026